Frankfurt - Delayed Quote • EUR
Kezar Life Sciences, Inc. (2KZ.F)
As of 8:04 AM GMT+2. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | 2KZ.F | S&P 500 |
---|---|---|
YTD | -10.91% | +7.04% |
1-Year | -65.97% | +25.39% |
3-Year | -83.95% | +22.14% |